Hasanali SL, Morera DS, Racine RR, Hennig M, et al. HYAL4-V1/Chondroitinase (Chase) Drives Gemcitabine Resistance and Predicts Chemotherapy Failure in Patients with Bladder Cancer. Clin Cancer Res 2021 May 24. pii: 1078-0432.CCR-21-0422.
PMID: 34031055